Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.90)
# 635
Out of 4,900 analysts
83
Total ratings
41.25%
Success rate
14.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRNA Verona Pharma | Maintains: Overweight | $76 → $160 | $104.77 | +52.72% | 3 | Jun 23, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $26.35 | +196.02% | 1 | Jun 12, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $110 → $81 | $6.23 | +1,201.20% | 3 | May 27, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $83.59 | +73.47% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $13.38 | +281.17% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $1.15 | +421.74% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $4.80 | +900.00% | 1 | Feb 28, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $24.36 | +281.77% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $11.15 | +572.95% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $105 | $23.80 | +341.18% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $52 → $26 | $9.17 | +183.53% | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $21.02 | +76.02% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $1.30 | +1,900.00% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.83 | +3,260.94% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $31.83 | +204.74% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $51.89 | +420.33% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $21.57 | +252.34% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $4.18 | +498.09% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.47 | +140.58% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $3.93 | +205.34% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $4.62 | +1,848.05% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $12.66 | +1,321.80% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.45 | +934.48% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $311.14 | +7.99% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.29 | +598.69% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $26.67 | +199.96% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $19.23 | +383.62% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $18.56 | +250.22% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $17.49 | +225.90% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $9.49 | +606.01% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $55.32 | -36.73% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $6.59 | +1,221.18% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $8.50 | +1,958.82% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $38.01 | +89.42% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $1.39 | +1,842.45% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $10.51 | +80.78% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $3.03 | +1,550.17% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.69 | +5,697.10% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.39 | +4,469.22% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $15.83 | +2,553.19% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $13.15 | +485.55% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $51.97 | +48.16% | 1 | Jul 31, 2020 |
Verona Pharma
Jun 23, 2025
Maintains: Overweight
Price Target: $76 → $160
Current: $104.77
Upside: +52.72%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $26.35
Upside: +196.02%
Prothena Corporation
May 27, 2025
Maintains: Overweight
Price Target: $110 → $81
Current: $6.23
Upside: +1,201.20%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $83.59
Upside: +73.47%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $13.38
Upside: +281.17%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.15
Upside: +421.74%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $4.80
Upside: +900.00%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $24.36
Upside: +281.77%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $11.15
Upside: +572.95%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $23.80
Upside: +341.18%
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $9.17
Upside: +183.53%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $21.02
Upside: +76.02%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.30
Upside: +1,900.00%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.83
Upside: +3,260.94%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $31.83
Upside: +204.74%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $51.89
Upside: +420.33%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $21.57
Upside: +252.34%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $4.18
Upside: +498.09%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.47
Upside: +140.58%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $3.93
Upside: +205.34%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $4.62
Upside: +1,848.05%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $12.66
Upside: +1,321.80%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.45
Upside: +934.48%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $311.14
Upside: +7.99%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.29
Upside: +598.69%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $26.67
Upside: +199.96%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $19.23
Upside: +383.62%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $18.56
Upside: +250.22%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $17.49
Upside: +225.90%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $9.49
Upside: +606.01%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $55.32
Upside: -36.73%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $6.59
Upside: +1,221.18%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $8.50
Upside: +1,958.82%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $38.01
Upside: +89.42%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $1.39
Upside: +1,842.45%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $10.51
Upside: +80.78%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $3.03
Upside: +1,550.17%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.69
Upside: +5,697.10%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.39
Upside: +4,469.22%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $15.83
Upside: +2,553.19%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $13.15
Upside: +485.55%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $51.97
Upside: +48.16%